Drug Type Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Preclinical | United Kingdom | 28 Apr 2025 | |
Castration-Resistant Prostatic Cancer | Preclinical | United States | 28 Apr 2025 |